| David Bailey Wilson, MD | |
|
550 Redmond Rd Nw, Rome, GA 30165-1416 | |
| (706) 233-8508 | |
| (706) 233-8509 |
| Full Name | David Bailey Wilson |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 30 Years |
| Location | 550 Redmond Rd Nw, Rome, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619947017 | NPI | - | NPPES |
| 003111624A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 066339 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Redmond Regional Medical Center | Rome, GA | Hospital |
| Floyd Medical Center | Rome, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Harbin Clinic Llc | 0446154231 | 264 |
News Archive
Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL in which Biovail acquired certain AMPAKINE compounds and the rights to the patent filing for respiratory depression and vaso-occlusive crises associated with sickle cell disease.
For patients treated with definitive radiation therapy (RT) for oropharyngeal cancer caused by human papillomavirus (HPV), the majority of recurrences can be detected by post-treatment imaging at three months and physical exams during the six months following treatment, according to research presented at the 2016 Multidisciplinary Head and Neck Cancer Symposium.
Brain-computer interfaces are at the cutting edge for treatment of neurological and psychological disorder, including Parkinson's, epilepsy, and depression. Among the most promising advance is deep brain stimulation (DBS) - a method in which a silicon chip implanted under the skin ejects high frequency currents that are transferred to the brain through implanted electrodes that transmit and receive the signals.
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office for a divisional patent of Patent Number 8,236,780 "Galactose-prolonged polysaccharides in a formulation for antifibrotic therapies".
One of the most controversial topics in neurology today is the prevalence of serious permanent brain damage after traumatic brain injury. Long-term studies and a search for genetic risk factors are required in order to predict an individual's risk for serious permanent brain damage, according to a review article published by Sam Gandy, MD, PhD, from the Icahn School of Medicine at Mount Sinai in a special issue of Nature Reviews Neurology dedicated to TBI.
› Verified 5 days ago
| Entity Name | Harbin Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679599088 PECOS PAC ID: 0446154231 Enrollment ID: O20031124000117 |
News Archive
Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL in which Biovail acquired certain AMPAKINE compounds and the rights to the patent filing for respiratory depression and vaso-occlusive crises associated with sickle cell disease.
For patients treated with definitive radiation therapy (RT) for oropharyngeal cancer caused by human papillomavirus (HPV), the majority of recurrences can be detected by post-treatment imaging at three months and physical exams during the six months following treatment, according to research presented at the 2016 Multidisciplinary Head and Neck Cancer Symposium.
Brain-computer interfaces are at the cutting edge for treatment of neurological and psychological disorder, including Parkinson's, epilepsy, and depression. Among the most promising advance is deep brain stimulation (DBS) - a method in which a silicon chip implanted under the skin ejects high frequency currents that are transferred to the brain through implanted electrodes that transmit and receive the signals.
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office for a divisional patent of Patent Number 8,236,780 "Galactose-prolonged polysaccharides in a formulation for antifibrotic therapies".
One of the most controversial topics in neurology today is the prevalence of serious permanent brain damage after traumatic brain injury. Long-term studies and a search for genetic risk factors are required in order to predict an individual's risk for serious permanent brain damage, according to a review article published by Sam Gandy, MD, PhD, from the Icahn School of Medicine at Mount Sinai in a special issue of Nature Reviews Neurology dedicated to TBI.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Bailey Wilson, MD 221 Technology Pkwy Nw, Rome, GA 30165-1369 Ph: (762) 235-1000 | David Bailey Wilson, MD 550 Redmond Rd Nw, Rome, GA 30165-1416 Ph: (706) 233-8508 |
News Archive
Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL in which Biovail acquired certain AMPAKINE compounds and the rights to the patent filing for respiratory depression and vaso-occlusive crises associated with sickle cell disease.
For patients treated with definitive radiation therapy (RT) for oropharyngeal cancer caused by human papillomavirus (HPV), the majority of recurrences can be detected by post-treatment imaging at three months and physical exams during the six months following treatment, according to research presented at the 2016 Multidisciplinary Head and Neck Cancer Symposium.
Brain-computer interfaces are at the cutting edge for treatment of neurological and psychological disorder, including Parkinson's, epilepsy, and depression. Among the most promising advance is deep brain stimulation (DBS) - a method in which a silicon chip implanted under the skin ejects high frequency currents that are transferred to the brain through implanted electrodes that transmit and receive the signals.
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office for a divisional patent of Patent Number 8,236,780 "Galactose-prolonged polysaccharides in a formulation for antifibrotic therapies".
One of the most controversial topics in neurology today is the prevalence of serious permanent brain damage after traumatic brain injury. Long-term studies and a search for genetic risk factors are required in order to predict an individual's risk for serious permanent brain damage, according to a review article published by Sam Gandy, MD, PhD, from the Icahn School of Medicine at Mount Sinai in a special issue of Nature Reviews Neurology dedicated to TBI.
› Verified 5 days ago
Gary Marc Wetherington, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 506 Riverside Pkwy Ne, Suite 200, Rome, GA 30161 Phone: 706-291-4334 Fax: 706-291-0248 | |
Peter David Adams, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1825 Martha Berry Blvd Nw, Rome, GA 30165 Phone: 706-295-5331 Fax: 706-236-6432 | |
Delmar Michael Rogers, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 796 N Division St Nw, Rome, GA 30165 Phone: 762-235-3760 Fax: 706-232-4131 | |
Christopher Lee Robinson, MD Surgery Medicare: Medicare Enrolled Practice Location: 550 Redmond Rd Nw, Rome, GA 30165 Phone: 706-233-8500 Fax: 706-233-8501 | |
James Dudley Riley, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1825 Martha Berry Blvd Nw, Rome, GA 30165 Phone: 706-295-5331 Fax: 706-236-6432 | |
Frank Durham Stegall Jr., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 550 Redmond Rd Nw, Rome, GA 30165 Phone: 706-233-8508 Fax: 706-233-8509 | |
John Ryland Scott, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1825 Martha Berry Blvd Nw, Rome, GA 30165 Phone: 706-295-5331 Fax: 706-236-6432 |